BofA raised the firm’s price target on American Healthcare REIT (AHR) to $27 from $19 and keeps a Buy rating on the shares after having hosted management meetings and coming away with a greater appreciation for the duration of internal growth, the strength of the Trilogy platform and the external growth opportunity. The firm believes American Healthcare will re-rate higher with further investor education and ultimately trade at a higher AFFO multiple than Ventas (VTR), the analyst tells investors post the meetings.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AHR:
- American Healthcare REIT files ot sell 3.5M shares of common stock for holders
- American Healthcare REIT files automatic mixed securities shelf
- American Healthcare REIT price target raised to $19 from $16 at BofA
- American Healthcare REIT price target raised to $18 from $16 at JMP Securities
- American Healthcare REIT Releases Q2 Supplemental Data